Quansys Biosciences
Business Services · Utah, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
365 N 600 W, Logan, Utah, 84321, United ...Phone Number
(435) 752-0531Website
www.quansysbio.comRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Quansys Biosciences
Quansys Biosciences specializes in developing multiplex kits that assist researchers in understanding diseases through their innovative Q-plex technology. Their product offerings include multiplex and singleplex assays, sample testing, imaging and software solutions, as well as custom assay kits and OEM manufacturing services. The company aims to provide accurate and reliable data on multiple biomarkers, catering to a diverse range of research needs. Quansys Biosciences serves clients in the scientific and research community, focusing on enhancing laboratory workflows and data analysis.Explore more
Quansys Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Quansys Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Quansys Biosciences recently announced quarterly report
Product Launch: Get notified when Quansys Biosciences launches new products
Funding: Get notified immidiatlly once Quansys Biosciences has new funding data
Quansys Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Quansys Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Quansys Biosciences
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Quansys Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Quansys Biosciences had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Quansys Biosciences
Compare insights from companies similar to Quansys Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Quansys Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Quansys Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Quansys Biosciences.
Quansys Biosciences financials insights
Gather financial insights about Quansys Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$300K
Quansys Biosciences Tech Stack
A closer look at the technologies used by Quansys Biosciences
See more technologies
Quansys Biosciences News & Media
PATH and Quansys Biosciences release Enhanced Micronutrient Biomarker Assay
LOGAN, Utah, June 1, 2022 /PRNewswire/ -- Micronutrient deficiencies disproportionately affect women and children in low- and middle-income countries. Such deficiencies can lead to systemic and enduring morbidities in individuals and their children, and if left untreated can contribute to...Quansys Biosciences Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test that Provides Exceptional Clinical Performance
LOGAN, Utah, Nov. 5, 2020 /PRNewswire/ -- Quansys Biosciences announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its laboratory-based IgG antibody test. A positive IgG antibody result identifies patients who have been...Quansys Biosciences Releases Multiplex Human Serological SARS-CoV-2 (4-plex) ELISA
LOGAN, Utah, April 15, 2020 /PRNewswire/ -- Quansys Biosciences in Logan, Utah, released their SARS-CoV-2 Human IgG(4-plex) enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of SARS-CoV-2 reactive IgG class antibodies in human serum and plasma. SARS-CoV-2 is the...New Diagnostic Will Help Propel Development of Improved Malaria Tests and Support Surveillance
PATH and Quansys Biosciences, Inc. have announced the launch of the Q-Plex™ Human Malaria Array (5-Plex), designed to help researchers develop more sensitive and reliable rapid diagnostic tests (RDTs) and to support public health surveillance. (PRWeb May 30, 2019) Read the full story at https://www.prweb.com/releases/new_diagnostic_will_help_propel_development_of_improved_malaria_tests_and_support_surveillance/prweb16345325.htm
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Quansys Biosciences
Sign Up For FreeTo access detailed company insights
Quansys Biosciences specializes in developing multiplex kits that assist researchers in understanding diseases through their innovative Q-plex technology. Their product offerings include multiplex and singleplex assays, sample testing, imaging and software solutions, as well as custom assay kits and OEM manufacturing services. The company aims to p... Read More
